Tocilizumab for severe COVID-19: A promising intervention affecting inflammation and coagulation
Marcel Levi
Topics & Concepts
MedicineTocilizumabCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)InflammationCoagulationImmunologyVirologyInternal medicineRheumatoid arthritisOutbreakDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19